Jens‐Oliver Koopmann

Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery

Suzanne I.S. Mosely, John E. Prime, Richard C.A. Sainson et al. · Cancer Immunology Research · 2016 · 407 citations

Immunology, Immunoediting, Immunotherapeutic Drug Discovery +21

A Viral ER-Resident Glycoprotein Inactivates the MHC-Encoded Peptide Transporter

Hartmut Hengel, Jens‐Oliver Koopmann, Thomas Flohr et al. · Immunity · 1997 · 316 citations · Full text

Immunology, Antiviral Response, Virology +5

Export of Antigenic Peptides from the Endoplasmic Reticulum Intersects with Retrograde Protein Translocation through the Sec61p Channel

Jens‐Oliver Koopmann, Jörn C. Albring, Eva N. Huter et al. · Immunity · 2000 · 153 citations · Full text

Protein Secretion, Signal Transduction, Biochemistry +13

Translocation of long peptides by transporters associated with antigen processing (TAP)

Jens‐Oliver Koopmann, Markus Post, Jacques Neefjes et al. · European Journal of Immunology · 1996 · 151 citations

The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment

Edmund Poon, Stefanie Mullins, Amanda Watkins et al. · Journal for ImmunoTherapy of Cancer · 2017 · 73 citations · Full text